Oncology Flashcards
1
Q
Cancer therapy timings
- Adjuvant
- Neo-adjuvant
- Concurrent
A
- Given after definitive treatment
- Given before main treatment to shrink cancer
- 2+ cancer therapies given simultaneously
2
Q
Radiotherapy
- Side effects - early
- Side effects - late
A
- Fatigue, pain, oesophagitis, pneumonitis, diarrhoea, N+V, skin reaction, cystitis, raised ICP, hair loss
- Fibrosis, stricture, osteonecrosis, fracture, malignancy
3
Q
Chemotherapy
- Frequency of administration
- Blood count lowest when
- How many cycles
A
- 2-4 weeks to allow for blood count recovery
- 2 weeks (neutropaenia, thrombocytopaenia)
- 6 cycles - 5 months
4
Q
Neutropaenic sepsis
- Triad
- Neutropaenia - definition
- Commonest cancers (2)
- Sepsis 6
A
- Neutropenia, anaemia, thrombocytopenia
- Neutrophil count <1.0
- Lymphoma, leukaemia
4. ABG - lactate, blood cultures, urine output IV ABX (Taz/Gent, Mero + Vanc), oxygen, IV fluids
5
Q
Chemotherapy hypersensitivity reaction
- Presentation
- Management
A
- Fever, low BP/O2, high HR, wheeze, OP oedema
2. Stop infusion Supportive - stat O2 + IV fluids Anti-histamine - 10mg chlorphenamine IV steroid - hydrocortisone 200mg Adrenaline 0.5ml of 1:1000 IM
6
Q
Tumour lysis syndrome
- Risk factors (4)
- Presentation (5)
- Preventative drug
- Clinical definition
- Scoring system
A
- Treatment of bulky chemosensitive tumours, anti-cancer therapy use, existing renal impairment, malignant biochemical abnormalities
- High: urate, K+, phosphate
Low Ca2+
Renal failure - Allopurinol/rasburicase immediately prior to + during 1st days of chemotherapy
- Laboratory TLS plus one or more of the following:
High serum creatinine (1.5x upper limit of normal)
Cardiac arrhythmia or sudden death
Seizure - Cairo-Bishop
7
Q
Fitness in oncology
- Name of fitness scale
- Scale
- Fitness investigations for possible: surgery
- Chemotherapy
- Radiotherapy
A
- ECOG
- 0 = fully active, 5 = deceased
- Lung, cardiac
- Renal, liver
- Ability to lie flat, pacemaker
8
Q
Lung cancer
- When to refer using suspected LC pathway (2)
- Urgent (2w) CXR in 40+ if
- Staging - investigations (2 stages)
- Further imaging in N-SCLC to establish eligibility for curative treatment
- Histology most associated with smoking
- Most associated with non-smoking
Endocrine extra-pulmonary manifestations
- Small cell (2)
- Squamous cell (1)
- Large cell (1)
- Other non-endocrine issues
A
- CXR findings suggest lung cancer
Aged 40+ with unexplained haemoptysis - 2+ unexplained symptoms, or smoke + 1 US:
Cough / fatigue / SOB / chest pain / weight loss / appetite loss - Thorax and abdomen CT with contrast
Then bronchoscopy and biopsy - PET scan
- Squamous cell carcinoma (near large airway, has clubbing)
- Adenocarcinoma (peripheral)
- ACTH (Cushing’s), ADH (dilutional low Na+)
- PTH (hypercalcaemia)
- HCG (gynaecomastia)
- Cerebellar degeneration, myopathy, polyneuropathy, myasthenic syndrome (Lambert-Eaton, when immune cells attack NMJs), thrombophlebitis migrans, anaemia, DIC, dermatomyositis, herpes zoster, acanthosis nigricans, clubbing, HPOA
9
Q
Bony metastases
- How quickly is MRI needed if MSCC suspected
- First symptom
- If bony metastases suspected but no compression
- Management
- Pre-neurosurgery investigations (2)
A
- 24 hours
- Back pain
- 1 week
- Nursed flat, catheter
High dose dexamethasone (16mg orally BD) + PPI
Opioid analgesia
Consider: neurosurgery, radiotherapy - CXR, CT thorax/abdo
10
Q
Acute hypercalcaemia
- Features
- Malignant causes
- Management
A
- Bones, stones, groans + psychic moans
Also: corneal calcification, short QT, HTN - Bone metastases, osteolytic tumours (e.g. myeloma), paraneoplastic syndrome (e.g. PTHrP from squamous cell LC), tumours producing vitamin D
- Rehydration (3-4L per day) + Zolendronic acid (IV)
11
Q
Palliative care - management
- Anorexia
- Bowel colic and excessive respiratory secretions
- Convulsions
- Hiccups
- Dysphonia
- Muscle spasm
- N+V
- Restlessness/confusion
A
- Prednisolone / dexamethasone
- Hyoscine hydrobromide (bowel = butyl) (antimuscarinic)
- Prophylactic phenytoin / carbamazepine
- Chlorpromazine / haloperidol
- Morphine / diazepam
- Diazepam / baclofen
- Haloperidol / metroclopromide / ondansetron
- Haloperidol
12
Q
Cytotoxic drugs - side effects
- Asparagine
- Cisplatin
- Vincristine/vinblastine
- Bleomycin
- Doxorubicin
- Cyclophosphamide
- Methotrexate
A
- Neurotoxicity
- Ototoxic, nephrotoxic (amifostine), low Mg2+
- ‘Christ my nerves (PN), blast my bones (myelosuppression)’
- Pulmonary fibrosis
- Cardiotoxic (dexrozoxane)
- Nephrotoxic, bladder toxic e.g. haemorrhagic cystitis (mesna)
- Nephrotoxic (leucovorin), myelosuppression (filgrastim), liver fibrosis, mucositis
13
Q
Tumour markers
Monoclonal antibodies
- CA 15-3
- CA 19-9
- CA 125
Tumour antigens
- PSA
- Alfa-feto protein (AFP) (2)
- Carcinoembryonic antigen (CEA)
- S-100 (2)
- Bombesin (3)
- Calcitonin
A
- Breast
- Pancreatic
- Ovarian
- Prostate carcinoma
- Hepatocellular carcinoma, testicular teratoma
- Colorectal cancer
- Melanoma, schwannomas
- Small cell lung carcinoma, gastric cancer, neuroblastoma
- Medullary thyroid cancer
14
Q
Genetics
- BRCA 1
- BRCA 2
- Li-Fraumeni syndrome (AD) - which gene, which malignancies (2)
- Lynch syndrome aka HNPCC (AD) (2)
- High risk identified using what
- Gardners syndrome - what it is (AD)
- Extra-colonic manifestation
- Which gene mutated
- Variant of what
A
- Breast (60%), ovarian (55%)
- Breast (60%), ovarian (25%), prostate
- p53 mutation - sarcoma, leukaemia
- Colonic, endometrial
- Amsterdam criteria (FAP excluded - no polyps)
- Familial colorectal polyposis
- Skull osteoma, thyroid cancer, epidermoid cysts, desmoid tumours
- APC
- Familial adenomatous polyposis (FAP)
15
Q
Genes - type
- Cyclin D1.EGF
- p16
- p53
A
- Growth-promoting oncogene
- Tumour suppressor gene
- Tumour suppressor gene